Table 2.
Serum HBV DNA ad-levels of the patients who developed to ACLF or not
| Groups | n | HBV DNA (IU/ml), n (%) | Log (HBV DNA), mean ± SD |
|||||
|---|---|---|---|---|---|---|---|---|
| <10 | ≥10 | <2000 | ≥2000 | <2 × 106 | ≥2 × 106 | |||
| Non-ACLF | 68 | 4 (5.9) | 64 (94.1) | 22 (32.4) | 46 (67.6) | 56(82.4) | 12(17.6) | 4.32 ± 1.99 |
| ACLF before admission | 26 | 1 (3.80) | 25 (96.2) | 7 (26.9) | 19 (73.1) | 20(76.9) | 6(23.1) | 4.65 ± 1.99 |
| ACLF after admission | 17 | 0 (0.0) | 17 (100.0) | 7(41.2) | 10 (58.8) | 15(88.2) | 2(11.8) | 4.27 ± 1.94 |
| Total | 111 | 5 (4.5) | 106 (95.5) | 36 (32.4) | 75 (67.6) | 91(82.0) | 20(18.0) | 4.39 ± 1.97 |
1. Groups: Non-ACLF, patients without ACLF development; ACLF, patients with ACLF development;
2. HBV DNA <10 IU/ml or ≥ 10 IU/ml: Fisher’s exact test, P = 0.827
3. HBV DNA <2000 IU/ml or ≥ 2000 IU/ml: χ2 = 0.953, P = 0.597
4. HBV DNA <2 × 106 IU/ml or ≥ 2 × 106 IU/ml: Fisher’s exact test, P = 0.643
5. Log(HBV DNA) (logarithm of the serum HBV DNA ad-level): F = 0.304, P = 0.739